CareRx Reports Voting Results from Annual General Meeting of Shareholders

TORONTO, June 7, 2022 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the nominees listed in the Management Information Circular for the Annual General Meeting of Shareholders (the "Meeting"), which was held on June 7, 2022, were elected as directors of the Company. In addition, all other resolutions put to vote at the Meeting were passed.

The results of the vote for the election of directors at the Meeting are as follows:


Votes For

Kevin Dalton

35,741,815 (99.496%)

Ralph Desando

33,253,023 (92.568%)

Matt Hills

34,290,831 (95.457%)

Keith McIntosh

33,790,865 (94.065%)

Bruce Moody

33,366,981 (92.885%)

David Murphy

33,832,184 (94.181%)

Maria Perrella

35,910,966 (99.967%)

Jack Shevel

33,208,320 (92.444%)


About CareRx Corporation

CareRx is Canada's leading provider of pharmacy services to seniors living communities. We serve approximately 96,000 residents in over 1,600 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes). We are a national organization with a large network of pharmacy fulfillment centres strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimes. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.

SOURCE CareRx Corporation

For further information: visit or contact: David Murphy, President & Chief Executive Officer, CareRx Corporation, 416-927-8400; Lawrence Chamberlain, Investor Relations, LodeRock Advisors, 416-519-4196,